James  Coffin net worth and biography

James Coffin Biography and Net Worth

COO of GeneDx
James Coffin, PhD also known as Jamie, is a pioneer in the healthcare and life sciences sector. As President and Chief Operating Officer at Sema4, he is responsible for business development and growth, sales, client services, and lab operations.

Before joining Sema4, Jamie served as Chief Executive Officer and President at Source Medical Solutions, the leading provider of practice management and EMR solutions in the ambulatory surgical space. Previously, Jamie was Worldwide Vice President and General Manager at Dell, leading the Global Healthcare Life Science business over a six-year period to become the premier healthcare IT services company in the world with $3.5 billion in revenue, and a workforce of approximately 13,000 people. He pioneered Dell’s efforts to apply leading-edge information technology into areas including EMR, data analytics, high performance and cloud computing, personalized medicine, claims processing, medical imaging, and pharmaceutical and biotech drug discovery.

Prior to Dell, Jamie served as Worldwide Vice President of IBM Healthcare and Life Sciences and grew the division to a $6.5 billion business. He was also a Director at Terascala, a company that accelerated big data applications.

Jamie earned his PhD from the University of Arkansas and his BS in Chemistry from Louisiana Tech University.

How do I contact James Coffin?

The corporate mailing address for Dr. Coffin and other GeneDx executives is 333 Ludlow Street North Tower 8th Floor, Stamford CT, 06902. GeneDx can also be reached via phone at 800-298-6470 and via email at [email protected]. Learn More on James Coffin's contact information.

Has James Coffin been buying or selling shares of GeneDx?

James Coffin has not been actively trading shares of GeneDx during the last quarter. Most recently, James Coffin sold 174 shares of the business's stock in a transaction on Monday, October 25th. The shares were sold at an average price of $248.82, for a transaction totalling $43,294.68. Learn More on James Coffin's trading history.

Who are GeneDx's active insiders?

GeneDx's insider roster includes Shawn Assad (CAO), Daniel Clark (General Counsel), James Coffin (COO), Anthony Prentice (Insider), Isaac Ro (CFO), and Eric Schadt (CEO). Learn More on GeneDx's active insiders.

Are insiders buying or selling shares of GeneDx?

In the last year, GeneDx insiders bought shares 5 times. They purchased a total of 116,742 shares worth more than $491,562.34. In the last year, insiders at the sold shares 34 times. They sold a total of 78,499 shares worth more than $448,078.10. The most recent insider tranaction occured on March, 18th when CEO Katherine Stueland sold 8,559 shares worth more than $90,639.81. Insiders at GeneDx own 28.1% of the company. Learn More about insider trades at GeneDx.

Information on this page was last updated on 3/18/2024.

James Coffin Insider Trading History at GeneDx

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/25/2021Sell174$248.82$43,294.68View SEC Filing Icon  
See Full Table

James Coffin Buying and Selling Activity at GeneDx

This chart shows James Coffin's buying and selling at GeneDx by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

GeneDx Company Overview

GeneDx logo
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
Read More

Today's Range

Now: $9.13
Low: $9.10
High: $9.85

50 Day Range

MA: $6.48
Low: $3.00
High: $12.01

2 Week Range

Now: $9.13
Low: $1.16
High: $12.24

Volume

116,443 shs

Average Volume

270,572 shs

Market Capitalization

$237.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.72